The recent instability in global chains have highlighted the necessity of securing vital medications like Ivermectin. Relying on overseas producers exposes countries to considerable vulnerabilities, including delivery delays, price fluctuations, and even geopolitical concerns. Transitioning towards domestic procurement of Ivermectin offers a multit